IMMUPHARMA PLC
Specialty biopharmaceutical company developing peptide-based therapeutics.
IMM | IL
Overview
Corporate Details
- ISIN(s):
- GB0033711010
- LEI:
- 213800VZKGHXC7VUS895
- Country:
- United Kingdom
- Address:
- One, EC1A 7BL London
- Website:
- https://www.immupharma.co.uk/
Description
ImmuPharma PLC is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The company's primary focus is on creating novel treatments for serious medical conditions with significant unmet needs. Its core activities involve advancing a pipeline of drug candidates through research and various stages of clinical development, leveraging its expertise in peptide technology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2025-05-20 08:00 |
Notice of AGM
|
English | HTML • 12.4 KB | ||
| 2025-05-19 08:00 |
Final Results
|
English | HTML • 329.2 KB | ||
| 2025-04-01 08:00 |
Extension of Warrants in Incanthera to 30 Sep 2025
|
English | HTML • 20.3 KB | ||
| 2025-03-14 08:00 |
IMM attending Bio-Europe Spring 17-19 March,Milan
|
English | HTML • 15.9 KB | ||
| 2025-03-13 08:00 |
ImmuPharma proves unique Mechanism of Action-P140
|
English | HTML • 18.0 KB | ||
| 2025-02-21 12:36 |
Holding(s) in Company
|
English | HTML • 52.0 KB | ||
| 2025-02-13 08:00 |
£2.91m fundraising; related party transactions
|
English | HTML • 56.0 KB | ||
| 2025-01-28 13:57 |
Response to Share Price Movement
|
English | HTML • 13.9 KB | ||
| 2025-01-09 08:00 |
Breakthrough Findings into Autoimmune Diseases
|
English | HTML • 18.3 KB | ||
| 2025-01-08 08:00 |
IMM at JP MORGAN CONFERENCE & BIOTECH SHOWCASE
|
English | HTML • 14.7 KB | ||
| 2024-12-23 08:00 |
Change of Auditor
|
English | HTML • 11.2 KB | ||
| 2024-12-10 15:36 |
Holding(s) in Company
|
English | HTML • 52.1 KB | ||
| 2024-12-04 08:00 |
Appointment of Company Secretary
|
English | HTML • 14.4 KB | ||
| 2024-09-09 08:01 |
Extension of Warrants in Incanthera to 31 Mar 2025
|
English | HTML • 20.6 KB | ||
| 2024-09-09 08:00 |
Half-year Report
|
English | HTML • 327.1 KB |
Automate Your Workflow. Get a real-time feed of all IMMUPHARMA PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for IMMUPHARMA PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for IMMUPHARMA PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
